Papich Mark G, Davidson Gigi S, Fortier Lisa A
Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
J Am Vet Med Assoc. 2013 Jun 15;242(12):1674-8. doi: 10.2460/javma.242.12.1674.
To determine the concentration of doxycycline compounded from doxycycline hyclate tablets into liquid formulations for oral administration in veterinary species and stored for 28 days.
Evaluation study.
Doxycycline hyclate tablets (100 mg) crushed and mixed with a 50:50 mixture of syrup and suspension vehicles for oral administration to produce 3 batches each of 2 doxycycline formulations: 33.3 and 166.7 mg/mL.
Formulations were stored, protected from light, at room temperature (22° to 26°C [71.6° to 78.8°F]) and at a controlled cold temperature (refrigerated 2° to 8°C [35.6° to 46.4°F]). Doxycycline was extracted from the formulations, and concentration was measured by high-pressure liquid chromatography on days 0 (date of preparation), 1, 4, 7, 14, 21, and 28. Concentrations were compared with those of a US Pharmacopeial Convention reference standard. Formulation quality at each point was also assessed through color change, formulation consistency, and suspension uniformity.
On days 0, 1, 4, and 7, the concentration of each formulation was within 90% to 110% of the reference standard (range, 93% to 109%), which was deemed acceptable. However, doxycycline concentrations had decreased dramatically by day 14 and remained low for the duration of the study period. Doxycycline concentrations on days 14, 21, and 28 were all < 20% (range, 14% to 18%) of the reference standard, and the quality of the formulations decreased as well. No effect of storage temperatures on doxycycline concentration was identified.
The concentration of doxycycline, compounded from commercial tablets in the vehicles evaluated to yield doses of 33.3 and 166.7 mg/mL, cannot be assured beyond 7 days.
测定从盐酸多西环素片配制而成的兽用口服液体制剂中多西环素的浓度,并储存28天。
评估研究。
将盐酸多西环素片(100毫克)碾碎,与糖浆和混悬液载体按50:50的比例混合用于口服,制备2种多西环素制剂,每种制剂各3批,浓度分别为33.3毫克/毫升和166.7毫克/毫升。
制剂在室温(22°至26°C [71.6°至78.8°F])和受控冷藏温度(2°至8°C [35.6°至46.4°F])下避光储存。在第0天(制备日期)、第1天、第4天、第7天、第14天、第21天和第28天从制剂中提取多西环素,并通过高压液相色谱法测量其浓度。将浓度与美国药典会议参考标准的浓度进行比较。还通过颜色变化、制剂稠度和混悬均匀性评估每个时间点的制剂质量。
在第0天、第1天、第4天和第7天,每种制剂的浓度在参考标准的90%至110%范围内(范围为93%至109%),这被认为是可接受的。然而,到第14天时多西环素浓度急剧下降,并且在研究期间一直保持在低水平。第14天、第21天和第28天的多西环素浓度均低于参考标准的20%(范围为14%至18%),制剂质量也有所下降。未发现储存温度对多西环素浓度有影响。
由市售片剂在评估的载体中配制而成的多西环素制剂,其浓度为33.3毫克/毫升和166.7毫克/毫升,超过7天后其浓度无法得到保证。